Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Gadina

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Current Opinion in Immunology|November 9, 2016
Targeting cytokine signaling in autoimmunity: back to the future and beyondKiyoshi Hirahara, Daniella Schwartz, Massimo Gadina, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated PathologiesMadison Alexander, Yiming Luo, Giorgio Raimondi, et al.
Drugs|April 3, 2017
Erratum to: JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future ProspectsShubhasree Banerjee, Ann Biehl, Massimo Gadina, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 28, 2021
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, et al.
Drugs|June 14, 2017
Erratum to: JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future ProspectsShubhasree Banerjee, Ann Biehl, Massimo Gadina, et al.
Drugs|March 4, 2017
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future ProspectsShubhasree Banerjee, Ann Biehl, Massimo Gadina, et al.
Frontiers in Immunology|January 16, 2023
Editorial: JAK inhibition in autoimmune and inflammatory diseasesJean-Baptiste Telliez, Massimo Gadina, Kamran Ghoreschi, et al.
Frontiers in Immunology|November 5, 2019
Transcriptional, Epigenetic and Pharmacological Control of JAK/STAT Pathway in NK CellsGianluca Scarno, Giuseppe Pietropaolo, Chiara Di Censo, et al.
JCI Insight|February 6, 2019
Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cellsNathan Simon, Antonella Antignani, Stephen M Hewitt, et al.
Immunological Reviews|October 9, 2018
JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardiansHelena Stabile, Gianluca Scarno, Cinzia Fionda, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Current Opinion in Immunology|November 9, 2016
Targeting cytokine signaling in autoimmunity: back to the future and beyondKiyoshi Hirahara, Daniella Schwartz, Massimo Gadina, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated PathologiesMadison Alexander, Yiming Luo, Giorgio Raimondi, et al.
Drugs|April 3, 2017
Erratum to: JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future ProspectsShubhasree Banerjee, Ann Biehl, Massimo Gadina, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 28, 2021
A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?Christine Liu, Jacqueline Kieltyka, Roy Fleischmann, et al.
Drugs|June 14, 2017
Erratum to: JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future ProspectsShubhasree Banerjee, Ann Biehl, Massimo Gadina, et al.
Drugs|March 4, 2017
JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future ProspectsShubhasree Banerjee, Ann Biehl, Massimo Gadina, et al.
Frontiers in Immunology|January 16, 2023
Editorial: JAK inhibition in autoimmune and inflammatory diseasesJean-Baptiste Telliez, Massimo Gadina, Kamran Ghoreschi, et al.
Frontiers in Immunology|November 5, 2019
Transcriptional, Epigenetic and Pharmacological Control of JAK/STAT Pathway in NK CellsGianluca Scarno, Giuseppe Pietropaolo, Chiara Di Censo, et al.
JCI Insight|February 6, 2019
Tofacitinib enhances delivery of antibody-based therapeutics to tumor cells through modulation of inflammatory cellsNathan Simon, Antonella Antignani, Stephen M Hewitt, et al.
Immunological Reviews|October 9, 2018
JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardiansHelena Stabile, Gianluca Scarno, Cinzia Fionda, et al.
Pageof 13